Stock TOVX THERIVA BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Market Closed - Nyse
Other stock markets
 16:10:00 2024-06-25 EDT 		5-day change 1st Jan Change
0.2385 USD -2.49% Intraday chart for Theriva Biologics, Inc. -2.65% -44.55%
05-23 Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment MT
05-23 Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation CI

Evolution of the average Target Price on Theriva Biologics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f.oM_DdluotR-Xcy9rR-10bcE-pPQV7UXSF30OZ1ue3vQ.lYiwLyrv1lvAEntSMp0hN7dh8INNpjaceD5nUg3khsXDqIxCPPLefs4yag~298b5407cd774d84f4082dcf61f46dc9

Analyst Recommendations on Theriva Biologics, Inc.

Cantor Fitzgerald Initiates Coverage on Synthetic Biologics With Overweight Rating MT
History shows stocks can weather rate hike cycle RE
SYNTHETIC BIOLOGICS : Maxim Upgrades Synthetic Biologics to Buy From Hold; Price Target is $2.50 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2385 USD
Average target price
2 USD
Spread / Average Target
+738.57%
High Price Target
2 USD
Spread / Highest target
+738.57%
Low Price Target
2 USD
Spread / Lowest Target
+738.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Theriva Biologics, Inc.

Cantor Fitzgerald
Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Consensus Theriva Biologics, Inc.